thyroid gland papillary carcinoma (Cancer)
Information
- Disease name
- thyroid gland papillary carcinoma
- Disease ID
- DOID:3969
- Description
- "A differentiated thyroid gland carcinoma that is characterized by the small mushroom shape of the tumor which has a stem attached to the epithelial layer and arises from the follicular cells of the thyroid gland." [url:http\://cancergenome.nih.gov/cancersselected/thyroid, url:http\://en.wikipedia.org/wiki/Papillary_thyroid_cancer, url:https\://www.ncbi.nlm.nih.gov/pubmed/21455196]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03914300 | Active, not recruiting | Phase 2 | Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer | February 10, 2020 | October 31, 2024 |
| NCT04759911 | Recruiting | Phase 2 | Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer | February 26, 2021 | September 10, 2024 |
| NCT05003856 | Recruiting | N/A | Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule | August 29, 2022 | June 30, 2025 |
| NCT05575440 | Recruiting | Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer | April 22, 2022 | May 1, 2026 | |
| NCT06440850 | Recruiting | Phase 2 | Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation | November 30, 2024 | November 30, 2026 |
| NCT03506048 | Terminated | Phase 2 | Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer | January 16, 2019 | June 24, 2021 |
- Disase is a (Disease Ontology)
- DOID:0080525
- Cross Reference ID (Disease Ontology)
- GARD:12027
- Cross Reference ID (Disease Ontology)
- MESH:D000077273
- Cross Reference ID (Disease Ontology)
- MIM:188550
- Cross Reference ID (Disease Ontology)
- NCI:C4035
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:255029007
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0238463
- Exact Synonym (Disease Ontology)
- Papillary carcinoma of the Thyroid gland